8-K Announcements
6Material company update
Apr 28, 2026·SEC
Material company update
Apr 6, 2026·SEC
Material company update
Mar 6, 2026·SEC
McKesson Corporation(MCK)Earnings, Financials & Key Ratios
MCK•NYSE
$801.01
$98.11B mkt cap·31.1× P/E·Price updated May 6, 2026
AboutMcKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.Show more
- Revenue$359.05B+16.2%
- EBITDA$5.01B+9.8%
- Net Income$3.29B+9.8%
- EPS (Diluted)25.72+14.9%
- Gross Margin3.48%-12.0%
- EBITDA Margin1.39%-5.5%
- Operating Margin1.22%-4.2%
- Net Margin0.92%-5.6%
- ROIC540.64%+114.3%
- Interest Coverage18.03+8.6%
MCK Key Insights
McKesson Corporation (MCK) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong 5Y profit CAGR of 29.6%
- ✓17 consecutive years of dividend growth
- ✓High quality earnings: Operating CF exceeds net income
- ✓Share count reduced 4.5% through buybacks
- ✓Efficient asset utilization: 4.8x turnover
✗Weaknesses
- ✗Thin 5Y average net margin of 0.3%
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
MCK Price & Volume
McKesson Corporation (MCK) stock price & volume — 10-year historical chart
Loading chart...
MCK Growth Metrics
McKesson Corporation (MCK) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years7.21%
5 Years9.22%
3 Years10.8%
TTM15.49%
Profit CAGR
10 Years8.36%
5 Years29.64%
3 Years43.55%
TTM53.57%
EPS CAGR
10 Years15.16%
5 Years39.04%
3 Years52.65%
TTM59.42%
Return on Capital
10 Years19.36%
5 Years24.14%
3 Years29.24%
Last Year30.55%
MCK Recent Earnings
McKesson Corporation (MCK) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 10/12 qtrs (83%)●Beat Revenue 7/12 qtrs (58%)
Q1 2026Latest
Feb 4, 2026EPS
$9.34
Est $9.17
+1.9%
Revenue
$106.2B
Est $105.8B
+0.3%
Q4 2025
Nov 5, 2025EPS
$9.86
Est $9.03
+9.2%
Revenue
$103.2B
Est $104.1B
-0.9%
Q3 2025
Aug 6, 2025EPS
$8.26
Est $8.14
+1.5%
Revenue
$97.8B
Est $96.2B
+1.7%
Q2 2025
May 8, 2025EPS
$10.12
Est $9.83
+3.0%
Revenue
$90.8B
Est $94.3B
-3.7%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 4, 2026 | $9.34vs $9.17+1.9% | $106.2Bvs $105.8B+0.3% |
| Q4 2025 | Nov 5, 2025 | $9.86vs $9.03+9.2% | $103.2Bvs $104.1B-0.9% |
| Q3 2025 | Aug 6, 2025 | $8.26vs $8.14+1.5% | $97.8Bvs $96.2B+1.7% |
| Q2 2025 | May 8, 2025 | $10.12vs $9.83+3.0% | $90.8Bvs $94.3B-3.7% |
Based on last 12 quarters of dataView full earnings history →
MCK Peer Comparison
McKesson Corporation (MCK) competitors in Drug Wholesalers and Distributors — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 CAH | 46.36B | 197.00 | 30.54 | -1.87% | 0.62% | 3.99% | ||
 HSIC | 8.53B | 74.37 | 22.74 | 4.03% | 3.02% | 8.24% | 6.71% | 0.77 |
 CVS | 102.56B | 80.69 | 58.05 | 7.85% | 0.44% | 2.35% | 7.61% | 1.24 |
 CI | 72.68B | 275.66 | 12.43 | 11.26% | 2.26% | 15.08% | 11.54% | 0.75 |
 OMI | 171.11M | 2.24 | -0.16 | -74.19% | -39.85% | -21.12% | ||
 JNJ | 543.64B | 225.59 | 38.96 | 4.3% | 27.26% | 31.69% | 3.65% | 0.51 |
 PFE | 150.4B | 26.44 | 19.44 | -1.65% | 11.83% | 8.34% | 6.03% | 0.78 |
 MRK | 279.49B | 113.16 | 15.54 | 1.18% | 28.12% | 36.14% | 4.42% | 0.96 |
Compare MCK vs Peers
McKesson Corporation (MCK) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
MCK Income Statement
McKesson Corporation (MCK) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 198.53B | 208.36B | 214.32B | 231.05B | 238.23B | 263.97B | 276.71B | 308.95B | 359.05B | 397.96B |
| Revenue Growth % | 4.01% | 4.95% | 2.86% | 7.81% | 3.11% | 10.8% | 4.83% | 11.65% | 16.22% | 15.49% |
| Cost of Goods Sold | 187.84B | 197.97B | 203.56B | 219.65B | 226.65B | 251.32B | 264.84B | 296.75B | 346.57B | 384.53B |
| COGS % of Revenue | 94.62% | 95.01% | 94.98% | 95.07% | 95.14% | 95.21% | 95.71% | 96.05% | 96.52% | - |
| Gross Profit | 10.69B▲ 0% | 10.39B▼ 2.8% | 10.76B▲ 3.6% | 11.4B▲ 5.9% | 11.58B▲ 1.6% | 12.65B▲ 9.2% | 11.87B▼ 6.2% | 12.2B▲ 2.8% | 12.48B▲ 2.3% | 13.43B▲ 0% |
| Gross Margin % | 5.38% | 4.99% | 5.02% | 4.93% | 4.86% | 4.79% | 4.29% | 3.95% | 3.48% | 3.37% |
| Gross Profit Growth % | -2.33% | -2.77% | 3.56% | 5.93% | 1.6% | 9.21% | -6.17% | 2.81% | 2.32% | - |
| Operating Expenses | 7.33B | 7.47B | 7.68B | 8.39B | 8.07B | 9.93B | 7.42B | 8.28B | 8.11B | 8.27B |
| OpEx % of Revenue | 3.69% | 3.59% | 3.59% | 3.63% | 3.39% | 3.76% | 2.68% | 2.68% | 2.26% | - |
| Selling, General & Admin | 6.99B | 7.35B | 7.61B | 8.29B | 8B | 9.86B | 7.33B | 8.2B | 8.02B | 4.12B |
| SG&A % of Revenue | 3.52% | 3.53% | 3.55% | 3.59% | 3.36% | 3.73% | 2.65% | 2.65% | 2.23% | - |
| Research & Development | 341M | 125M | 71M | 96M | 74M | 70M | 89M | 77M | 91M | 0 |
| R&D % of Revenue | 0.17% | 0.06% | 0.03% | 0.04% | 0.03% | 0.03% | 0.03% | 0.02% | 0.03% | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2M |
| Operating Income | 3.36B▲ 0% | 2.92B▼ 13.0% | 3.08B▲ 5.4% | 3.01B▼ 2.1% | 3.51B▲ 16.5% | 2.72B▼ 22.4% | 4.45B▲ 63.5% | 3.93B▼ 11.8% | 4.37B▲ 11.3% | 5.16B▲ 0% |
| Operating Margin % | 1.69% | 1.4% | 1.44% | 1.3% | 1.47% | 1.03% | 1.61% | 1.27% | 1.22% | 1.3% |
| Operating Income Growth % | -12.83% | -12.99% | 5.37% | -2.14% | 16.53% | -22.42% | 63.53% | -11.81% | 11.33% | - |
| EBITDA | 4.27B | 3.87B | 4.03B | 3.93B | 4.73B | 3.72B | 5.31B | 4.56B | 5.01B | 5.84B |
| EBITDA Margin % | 2.15% | 1.86% | 1.88% | 1.7% | 1.99% | 1.41% | 1.92% | 1.48% | 1.39% | 1.47% |
| EBITDA Growth % | -9.9% | -9.26% | 4% | -2.31% | 20.26% | -21.29% | 42.59% | -14.09% | 9.78% | 14.34% |
| D&A (Non-Cash Add-back) | 910M | 951M | 949M | 922M | 1.22B | 1B | 857M | 635M | 636M | 684M |
| EBIT | 7.2B | 522M | 874M | 1.39B | -4.82B | 2.11B | 4.88B | 4.03B | 4.62B | 5.78B |
| Net Interest Income | -279M | -235M | -225M | -200M | -205M | -168M | -141M | -125M | -83M | -231M |
| Interest Income | 29M | 48M | 39M | 49M | 12M | 10M | 107M | 118M | 173M | 0 |
| Interest Expense | 308M | 283M | 264M | 249M | 217M | 178M | 248M | 243M | 256M | 231M |
| Other Income/Expense | 3.53B | -2.68B | -2.47B | -1.87B | -8.54B | -795M | 177M | -138M | -13M | 432M |
| Pretax Income | 6.89B▲ 0% | 239M▼ 96.5% | 610M▲ 155.2% | 1.14B▲ 87.5% | -5.03B▼ 540.0% | 1.93B▲ 138.3% | 4.63B▲ 140.1% | 3.79B▼ 18.2% | 4.36B▲ 15.0% | 5.59B▲ 0% |
| Pretax Margin % | 3.47% | 0.11% | 0.28% | 0.5% | -2.11% | 0.73% | 1.67% | 1.23% | 1.21% | 1.4% |
| Income Tax | 1.61B | -53M | 356M | 18M | -695M | 636M | 905M | 629M | 878M | 1.04B |
| Effective Tax Rate % | 23.42% | -22.18% | 58.36% | 1.57% | 13.81% | 32.99% | 19.55% | 16.6% | 20.14% | 18.62% |
| Net Income | 5.18B▲ 0% | 67M▼ 98.7% | 34M▼ 49.3% | 900M▲ 2547.1% | -4.54B▼ 604.3% | 1.11B▲ 124.5% | 3.56B▲ 219.6% | 3B▼ 15.7% | 3.29B▲ 9.8% | 4.34B▲ 0% |
| Net Margin % | 2.61% | 0.03% | 0.02% | 0.39% | -1.91% | 0.42% | 1.29% | 0.97% | 0.92% | 1.09% |
| Net Income Growth % | 129.54% | -98.71% | -49.25% | 2547.06% | -604.33% | 124.54% | 219.57% | -15.67% | 9.76% | 53.57% |
| Net Income (Continuing) | 5.28B | 292M | 254M | 1.13B | -4.34B | 1.29B | 3.73B | 3.16B | 3.48B | 4.55B |
| Discontinued Operations | -11M | 5M | 1M | -6M | -1M | -5M | -3M | 0 | 0 | 0 |
| Minority Interest | 1.5B | 1.71B | 1.59B | 1.62B | 1.47B | 480M | 367M | 372M | 380M | 1.2B |
| EPS (Diluted) | 22.73▲ 0% | 0.32▼ 98.6% | 0.17▼ 46.9% | 4.95▲ 2811.8% | -27.02▼ 645.9% | 7.23▲ 126.8% | 25.04▲ 246.3% | 22.39▼ 10.6% | 25.72▲ 14.9% | 35.08▲ 0% |
| EPS Growth % | 134.33% | -98.59% | -46.88% | 2811.76% | -645.86% | 126.76% | 246.33% | -10.58% | 14.87% | 59.42% |
| EPS (Basic) | 22.95 | 0.32 | 0.17 | 4.97 | -27.02 | 7.31 | 25.23 | 22.54 | 25.86 | - |
| Diluted Shares Outstanding | 223M | 209M | 197.3M | 182M | 160.6M | 154.1M | 142.2M | 134.1M | 128.1M | 123.7M |
| Basic Shares Outstanding | 221M | 208M | 196.3M | 181M | 160.6M | 152.3M | 141.1M | 133.2M | 127.4M | 123.2M |
| Dividend Payout Ratio | 4.88% | 391.04% | 858.82% | 32.67% | - | 24.87% | 8.2% | 10.46% | 10.47% | - |
MCK Balance Sheet
McKesson Corporation (MCK) balance sheet — assets, liabilities & shareholders' equity
| Line item | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 36.95B | 37.14B | 38.47B | 42.22B | 45.38B | 46.23B | 44.29B | 47.97B | 55.4B | 59.7B |
| Cash & Short-Term Investments | 2.78B | 2.67B | 2.98B | 4.01B | 6.28B | 3.53B | 4.68B | 4.58B | 5.69B | 2.96B |
| Cash Only | 2.78B | 2.67B | 2.98B | 4.01B | 6.28B | 3.53B | 4.68B | 4.58B | 5.69B | 2.96B |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 18.21B | 17.71B | 18.25B | 19.95B | 19.18B | 18.58B | 19.41B | 21.62B | 25.64B | 28.21B |
| Days Sales Outstanding | 33.49 | 31.03 | 31.07 | 31.52 | 29.39 | 25.7 | 25.6 | 25.54 | 26.07 | 25.29 |
| Inventory | 15.28B | 16.31B | 16.71B | 16.73B | 19.25B | 18.7B | 19.69B | 21.14B | 23B | 27.07B |
| Days Inventory Outstanding | 29.69 | 30.07 | 29.96 | 27.81 | 30.99 | 27.16 | 27.14 | 26 | 24.22 | 24.03 |
| Other Current Assets | 0 | 0 | 0 | 906M | 12M | 4.52B | 513M | 626M | 1.06B | 1.46B |
| Total Non-Current Assets | 24.02B | 23.25B | 21.21B | 19.02B | 19.63B | 17.07B | 18.03B | 19.47B | 19.74B | 24.49B |
| Property, Plant & Equipment | 2.29B | 2.46B | 2.55B | 4.25B | 4.68B | 3.64B | 3.81B | 4.04B | 4.28B | 4.69B |
| Fixed Asset Turnover | 86.62x | 84.56x | 84.11x | 54.35x | 50.89x | 72.52x | 72.59x | 76.38x | 83.81x | 86.82x |
| Goodwill | 10.59B | 10.92B | 9.36B | 9.36B | 9.49B | 9.45B | 9.95B | 10.13B | 10.02B | 11.32B |
| Intangible Assets | 3.67B | 4.1B | 3.69B | 3.16B | 2.88B | 2.06B | 2.28B | 2.11B | 1.46B | 4.18B |
| Long-Term Investments | 4.06B | 3.73B | 3.51B | 170M | 72M | 0 | 312M | 348M | 0 | 416M |
| Other Non-Current Assets | 3.42B | 2.03B | 2.1B | 2.26B | 2.58B | 1.92B | 1.99B | 2.84B | 3.97B | 16.14B |
| Total Assets | 60.97B▲ 0% | 60.38B▼ 1.0% | 59.67B▼ 1.2% | 61.25B▲ 2.6% | 65.02B▲ 6.2% | 63.3B▼ 2.6% | 62.32B▼ 1.5% | 67.44B▲ 8.2% | 75.14B▲ 11.4% | 84.19B▲ 0% |
| Asset Turnover | 3.26x | 3.45x | 3.59x | 3.77x | 3.66x | 4.17x | 4.44x | 4.58x | 4.78x | 4.90x |
| Asset Growth % | 7.79% | -0.96% | -1.17% | 2.64% | 6.15% | -2.64% | -1.55% | 8.22% | 11.41% | 59.5% |
| Total Current Liabilities | 35.61B | 36.69B | 37.63B | 42.62B | 44.1B | 48.47B | 47.96B | 52.36B | 61.6B | 68.13B |
| Accounts Payable | 31.02B | 32.18B | 33.85B | 37.2B | 38.98B | 38.09B | 42.49B | 47.1B | 55.33B | 60.68B |
| Days Payables Outstanding | 60.28 | 59.33 | 60.7 | 61.81 | 62.77 | 55.31 | 58.56 | 57.93 | 58.27 | 55.72 |
| Short-Term Debt | 1.24B | 1.13B | 330M | 1.05B | 742M | 799M | 968M | 50M | 1.19B | 1.13B |
| Deferred Revenue (Current) | 346M | 63M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | -63M | 0 | 683M | 9M | 4.74B | 0 | 0 | 0 | 0 |
| Current Ratio | 1.04x | 1.01x | 1.02x | 0.99x | 1.03x | 0.95x | 0.92x | 0.92x | 0.90x | 0.90x |
| Quick Ratio | 0.61x | 0.57x | 0.58x | 0.60x | 0.59x | 0.57x | 0.51x | 0.51x | 0.53x | 0.53x |
| Cash Conversion Cycle | 2.9 | 1.77 | 0.33 | -2.48 | -2.38 | -2.46 | -5.82 | -6.38 | -7.98 | -6.4 |
| Total Non-Current Liabilities | 12.76B | 12.18B | 12.37B | 11.91B | 19.47B | 16.62B | 15.85B | 16.68B | 15.23B | 16.16B |
| Long-Term Debt | 7.3B | 6.75B | 7.26B | 6.33B | 6.41B | 5.08B | 4.63B | 5.58B | 4.46B | 5.42B |
| Capital Lease Obligations | 0 | 0 | 43M | 1.66B | 1.87B | 1.37B | 1.4B | 1.47B | 1.48B | 6.87B |
| Deferred Tax Liabilities | 3.68B | 2.8B | 3B | 2.25B | 1.41B | 1.42B | 1.39B | 917M | 1.03B | 4.21B |
| Other Non-Current Liabilities | 1.77B | 2.63B | 2.1B | 1.66B | 9.78B | 8.76B | 8.44B | 8.72B | 8.26B | 32.43B |
| Total Liabilities | 48.37B | 48.87B | 49.99B | 54.54B | 63.57B | 65.09B | 63.81B | 69.04B | 76.83B | 84.29B |
| Total Debt | 8.54B | 7.88B | 7.59B | 9.4B | 9.4B | 7.54B | 7.29B | 7.39B | 7.39B | 8.62B |
| Net Debt | 5.76B | 5.21B | 4.61B | 5.39B | 3.13B | 4.01B | 2.62B | 2.81B | 1.7B | 5.67B |
| Debt / Equity | 0.68x | 0.68x | 0.78x | 1.40x | 6.50x | - | - | - | - | -87.11x |
| Debt / EBITDA | 2.00x | 2.04x | 1.89x | 2.39x | 1.99x | 2.03x | 1.37x | 1.62x | 1.48x | 1.48x |
| Net Debt / EBITDA | 1.35x | 1.35x | 1.15x | 1.37x | 0.66x | 1.08x | 0.49x | 0.62x | 0.34x | 0.34x |
| Interest Coverage | 23.37x | 1.84x | 3.31x | 5.59x | -22.20x | 11.83x | 19.67x | 16.59x | 18.03x | 25.04x |
| Total Equity | 12.6B▲ 0% | 11.52B▼ 8.6% | 9.68B▼ 15.9% | 6.71B▼ 30.7% | 1.45B▼ 78.5% | -1.79B▼ 223.9% | -1.49B▲ 16.9% | -1.6B▼ 7.3% | -1.69B▼ 5.9% | -99M▲ 0% |
| Equity Growth % | 20.99% | -8.6% | -15.94% | -30.67% | -78.45% | -223.93% | 16.85% | -7.32% | -5.94% | 206.03% |
| Book Value per Share | 56.50 | 55.10 | 49.06 | 36.87 | 9.00 | -11.63 | -10.48 | -11.92 | -13.22 | -0.80 |
| Total Shareholders' Equity | 11.1B | 9.8B | 8.09B | 5.09B | -21M | -2.27B | -1.86B | -1.97B | -2.07B | -1.3B |
| Common Stock | 3M | 3M | 3M | 2M | 2M | 2M | 3M | 3M | 3M | 3M |
| Retained Earnings | 13.19B | 12.99B | 12.41B | 13.02B | 8.2B | 9.03B | 12.29B | 14.98B | 17.92B | 20.71B |
| Treasury Stock | -5.98B | -7.66B | -8.9B | -12.89B | -13.67B | -17.05B | -21B | -24.12B | -27.44B | -29.65B |
| Accumulated OCI | -2.14B | -1.72B | -1.85B | -1.7B | -1.48B | -1.53B | -905M | -881M | -932M | -903M |
| Minority Interest | 1.5B | 1.71B | 1.59B | 1.62B | 1.47B | 480M | 367M | 372M | 380M | 1.2B |
MCK Cash Flow Statement
McKesson Corporation (MCK) cash flow — operating, investing & free cash flow history
| Line item | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 4.74B | 4.34B | 4.04B | 4.37B | 4.54B | 4.43B | 5.16B | 4.31B | 6.08B | 6.08B |
| Operating CF Margin % | 2.39% | 2.09% | 1.88% | 1.89% | 1.91% | 1.68% | 1.86% | 1.4% | 1.69% | - |
| Operating CF Growth % | 29.19% | -8.41% | -7.11% | 8.37% | 3.84% | -2.38% | 16.35% | -16.38% | 41.05% | 287.25% |
| Net Income | 5.15B | 297M | 33M | 1.12B | -4.34B | 1.29B | 3.72B | 3.16B | 3.48B | 4.34B |
| Depreciation & Amortization | 910M | 951M | 949M | 922M | 887M | 760M | 608M | 635M | 636M | 340M |
| Stock-Based Compensation | 115M | 69M | 0 | 0 | 0 | 161M | 162M | 0 | 0 | 0 |
| Deferred Taxes | 882M | -868M | 189M | -342M | -908M | 34M | -20M | -603M | -110M | -252M |
| Other Non-Cash Items | -4B | 2.38B | 2.25B | 1.99B | 1.23B | 2.11B | 303M | 1.19B | 923M | 459M |
| Working Capital Changes | 1.69B | 1.52B | 614M | 689M | 7.67B | 82M | 384M | -64M | 1.16B | 5.38B |
| Change in Receivables | -762M | 1.18B | -967M | -2.49B | 1.15B | -1.84B | -1.08B | -2.95B | -3.94B | -2B |
| Change in Inventory | 320M | -458M | -368M | -376M | -2.28B | -1.17B | -1.26B | -1.29B | -2.27B | -3.23B |
| Change in Payables | 2.07B | 271M | 1.98B | 0 | 0 | 2.8B | 3.79B | 0 | 0 | 4.89B |
| Cash from Investing | -3.8B | -1.52B | -1.38B | -579M | -415M | -89M | -542M | -1.07B | -733M | -4.08B |
| Capital Expenditures | -562M | -580M | -557M | -506M | -641M | -535M | -558M | -431M | -537M | -169M |
| CapEx % of Revenue | 0.28% | 0.28% | 0.26% | 0.22% | 0.27% | 0.2% | 0.2% | 0.14% | 0.15% | - |
| Acquisitions | -2.8B | -2.39B | -804M | -133M | 365M | 572M | 210M | -225M | 155M | -3.34B |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -431M | 1.63B | 111M | 60M | -139M | -126M | -1.06B | -416M | -351M | -627M |
| Cash from Financing | -2.07B | -3.08B | -2.23B | -2.73B | -1.69B | -6.32B | -4.37B | -3.34B | -3.96B | -4.67B |
| Debt Issued (Net) | 393M | -948M | -16M | -298M | -540M | -1.15B | -277M | 56M | -21M | -1.79B |
| Equity Issued (Net) | -2.31B | -1.71B | -1.64B | -1.93B | -742M | -3.52B | -3.48B | -2.91B | -3.04B | -937M |
| Dividends Paid | -253M | -262M | -292M | -294M | -276M | -277M | -292M | -314M | -345M | -371M |
| Share Repurchases | -2.31B | -1.71B | -1.64B | -1.93B | -742M | -3.52B | -3.64B | -3.02B | -3.15B | -980M |
| Other Financing | 102M | -165M | -280M | -208M | -135M | -1.38B | -324M | -175M | -554M | -1.56B |
| Net Change in Cash | -1.26B▲ 0% | -111M▲ 91.2% | 309M▲ 378.4% | 1.04B▲ 237.2% | 2.38B▲ 128.5% | -2.46B▼ 203.4% | 744M▲ 130.2% | -94M▼ 112.6% | 1.37B▲ 1558.5% | 1.77B▲ 0% |
| Free Cash Flow | 4.18B▲ 0% | 3.77B▼ 10.0% | 3.48B▼ 7.6% | 3.87B▲ 11.2% | 3.9B▲ 0.9% | 3.9B▼ 0.1% | 4.6B▲ 18.0% | 3.63B▼ 21.2% | 5.23B▲ 44.1% | 10.1B▲ 0% |
| FCF Margin % | 2.11% | 1.81% | 1.62% | 1.67% | 1.64% | 1.48% | 1.66% | 1.17% | 1.46% | 2.54% |
| FCF Growth % | 39.63% | -9.97% | -7.6% | 11.18% | 0.85% | -0.05% | 18% | -21.17% | 44.09% | 517.87% |
| FCF per Share | 18.75 | 18.01 | 17.63 | 21.25 | 24.29 | 25.30 | 32.36 | 27.05 | 40.80 | 40.80 |
| FCF Conversion (FCF/Net Income) | 0.92x | 64.85x | 118.71x | 4.86x | -1.00x | 3.98x | 1.45x | 1.44x | 1.85x | 2.33x |
| Interest Paid | 315M | 298M | 383M | 235M | 220M | 186M | 224M | 234M | 273M | 0 |
| Taxes Paid | 587M | 144M | 262M | 368M | 379M | 359M | 562M | 901M | 1.12B | 0 |
MCK Key Ratios
McKesson Corporation (MCK) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 45.04% | 0.56% | 0.32% | 10.98% | -111.29% | - | - | - | - | -536.8% |
| Return on Invested Capital (ROIC) | 15.31% | 12.49% | 14.88% | 17.12% | 31.58% | 60.15% | 199.69% | 252.27% | 540.64% | 540.64% |
| Gross Margin | 5.38% | 4.99% | 5.02% | 4.93% | 4.86% | 4.79% | 4.29% | 3.95% | 3.48% | 3.37% |
| Net Margin | 2.61% | 0.03% | 0.02% | 0.39% | -1.91% | 0.42% | 1.29% | 0.97% | 0.92% | 1.09% |
| Debt / Equity | 0.68x | 0.68x | 0.78x | 1.40x | 6.50x | - | - | - | - | -87.11x |
| Interest Coverage | 23.37x | 1.84x | 3.31x | 5.59x | -22.20x | 11.83x | 19.67x | 16.59x | 18.03x | 25.04x |
| FCF Conversion | 0.92x | 64.85x | 118.71x | 4.86x | -1.00x | 3.98x | 1.45x | 1.44x | 1.85x | 2.33x |
| Revenue Growth | 4.01% | 4.95% | 2.86% | 7.81% | 3.11% | 10.8% | 4.83% | 11.65% | 16.22% | 15.49% |
MCK SEC Filings & Documents
McKesson Corporation (MCK) SEC filings — annual & quarterly reports (10-K, 10-Q)
MCK Frequently Asked Questions
McKesson Corporation (MCK) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
McKesson Corporation (MCK) reported $397.96B in revenue for fiscal year 2025. This represents a 2801% increase from $13.72B in 1996.
McKesson Corporation (MCK) grew revenue by 16.2% over the past year. This is strong growth.
Yes, McKesson Corporation (MCK) is profitable, generating $4.34B in net income for fiscal year 2025 (0.9% net margin).
Dividend & Returns
Yes, McKesson Corporation (MCK) pays a dividend with a yield of 0.34%. This makes it attractive for income-focused investors.
McKesson Corporation (MCK) generated $10.10B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Explore More MCK
McKesson Corporation (MCK) financial analysis — history, returns, DCA and operating performance tools
Full MCK Stock Analysis
Analyst verdict, bull/bear case, risk factors and peer comparison
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates